Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMRx2 vs Placebo in Hypertension
NCT04518306Phase 3Completed
- Sponsor
- George Medicines
- Start
- Jun 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 5
01
Overview
A Phase 3 trial of telmisartan + amlodipine + indapamide in hypertension (HTN), sponsored by George Medicines. Started Jun 2021; status: completed.
02
Drugs
telmisartan + amlodipine + indapamide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04518306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04518306.